Fadi Nasr

573 total citations
65 papers, 357 citations indexed

About

Fadi Nasr is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Fadi Nasr has authored 65 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 13 papers in Hematology. Recurrent topics in Fadi Nasr's work include Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (11 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Fadi Nasr is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (11 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Fadi Nasr collaborates with scholars based in Lebanon, United States and France. Fadi Nasr's co-authors include Joseph Kattan, Georges Chahine, Marwan Ghosn, Fadi Farhat, Fadi El Karak, Tarek Assi, Elie Rassy, Ziad Bakouny, Hampig Raphaël Kourié and Fadi Farhat and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Fadi Nasr

58 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fadi Nasr Lebanon 11 184 86 67 57 45 65 357
Andy Surinach United States 13 199 1.1× 81 0.9× 50 0.7× 70 1.2× 56 1.2× 74 430
Andrew Ip United States 8 196 1.1× 58 0.7× 60 0.9× 26 0.5× 21 0.5× 66 415
Penny Taylor United Kingdom 8 221 1.2× 48 0.6× 32 0.5× 36 0.6× 45 1.0× 10 396
Ankie M.T. van der Velden Netherlands 12 161 0.9× 65 0.8× 25 0.4× 37 0.6× 36 0.8× 18 368
Nahila Justo Sweden 10 150 0.8× 88 1.0× 32 0.5× 12 0.2× 28 0.6× 21 418
Robert Hettle United Kingdom 11 265 1.4× 95 1.1× 32 0.5× 27 0.5× 28 0.6× 63 547
Richard Welch United Kingdom 10 366 2.0× 286 3.3× 51 0.8× 51 0.9× 90 2.0× 26 762
Mathieu Puyade France 12 154 0.8× 84 1.0× 9 0.1× 87 1.5× 37 0.8× 57 461
Nikita Mehra India 10 78 0.4× 38 0.4× 21 0.3× 50 0.9× 50 1.1× 54 320
Seied Asadollah Mousavi Iran 10 88 0.5× 24 0.3× 19 0.3× 72 1.3× 16 0.4× 28 246

Countries citing papers authored by Fadi Nasr

Since Specialization
Citations

This map shows the geographic impact of Fadi Nasr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fadi Nasr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fadi Nasr more than expected).

Fields of papers citing papers by Fadi Nasr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fadi Nasr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fadi Nasr. The network helps show where Fadi Nasr may publish in the future.

Co-authorship network of co-authors of Fadi Nasr

This figure shows the co-authorship network connecting the top 25 collaborators of Fadi Nasr. A scholar is included among the top collaborators of Fadi Nasr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fadi Nasr. Fadi Nasr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kassab, Joseph, et al.. (2023). AI-based online chat and the future of oncology care: a promising technology or a solution in search of a problem?. Frontiers in Oncology. 13. 1176617–1176617. 10 indexed citations
2.
Kattan, Joseph, Fadi Farhat, Georges Chahine, et al.. (2022). Prevalence of Her2-neu status and its clinicopathological association in newly diagnosed gastric cancer patients. BMC Cancer. 22(1). 1114–1114. 4 indexed citations
3.
4.
Haddad, Sara F., et al.. (2021). Impact of ABO and Rhesus blood groups on COVID‐19 susceptibility and severity: A case‐control study. Journal of Medical Virology. 94(3). 1162–1166. 10 indexed citations
5.
Nasr, Fadi, et al.. (2021). Lebanese Real-World Experience in Treating Multiple Myeloma: A Multicenter Retrospective Study. SHILAP Revista de lepidopterología. 15. 100252–100252. 5 indexed citations
6.
Yaghi, César, et al.. (2021). Hemophagocytic lymphohistiocytosis, a new cause of death during ‘post-acute COVID-19 syndrome?’ A case report. Journal of Hematopathology. 14(3). 229–233. 13 indexed citations
7.
Hallit, Souheil, et al.. (2021). Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019. BMC Public Health. 21(1). 1820–1820. 7 indexed citations
8.
Bakouny, Ziad, Tarek Assi, Elie Rassy, & Fadi Nasr. (2018). Second-line Treatments of Advanced Hepatocellular Carcinoma. Journal of Clinical Gastroenterology. 53(4). 251–261. 20 indexed citations
9.
Rassy, Elie, Marwan Ghosn, Fadi Farhat, et al.. (2018). Toxicities Associated with Docetaxel-Based Regimens in the Adjuvant Treatment of Early-Stage Breast Cancer: A Multicenter Prospective Real-Life Experience. Breast Care. 13(2). 119–123. 2 indexed citations
10.
Bazarbachi, Ali, Radwan Massoud, Jean El Cheikh, et al.. (2017). Trends in hematopoietic stem cell transplant activity in Lebanon. Hematology/Oncology and Stem Cell Therapy. 10(4). 315–320. 5 indexed citations
11.
Nasr, Fadi, et al.. (2017). Adult Langerhans cell histiocytosis with pulmonary and colorectoanal involvement: a case report. Journal of Medical Case Reports. 11(1). 272–272. 5 indexed citations
12.
Nasr, Fadi, et al.. (2016). Adherence to Monitoring Tests in Patients With Chronic Myeloid Leukemia in Lebanon. Clinical Lymphoma Myeloma & Leukemia. 16. S101–S104. 1 indexed citations
13.
Assi, Tarek, Elie Rassy, Samer Tabchi, et al.. (2015). Treatment of cancer patients in their last month of life: aimless chemotherapy. Supportive Care in Cancer. 24(4). 1603–1608. 24 indexed citations
14.
Rassy, Elie, Samer Tabchi, Fadi Haddad, et al.. (2015). Acquired factor inhibitor in a patient with monoclonal gammopathy of undetermined significance responding to rituximab. Blood Coagulation & Fibrinolysis. 27(7). 822–824.
15.
Ibrahim, Tony, et al.. (2015). Late Recurrence of Low-Risk Stage II Colorectal Cancer Shortly After Etanercept. Journal of Gastrointestinal Cancer. 47(4). 506–508. 1 indexed citations
16.
Ghosn, Marwan, et al.. (2012). Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer. Medical Oncology. 29(4). 2831–2837. 8 indexed citations
17.
Ghosn, Marwan, Carla Hajj, Joseph Kattan, et al.. (2011). Triple-Negative Breast Cancer in Lebanon: A Case Series. The Oncologist. 16(11). 1552–1556. 10 indexed citations
18.
19.
Ghosn, Marwan, et al.. (2007). Sequential vinorelbine–capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial. Cancer Chemotherapy and Pharmacology. 62(1). 11–18. 9 indexed citations
20.
Faderl, Stefan, Deborah A. Thomas, Jörge E. Cortes, et al.. (1999). Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications. Leukemia. 13(6). 869–872. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andy Surinach Breakdown of academic impact, for papers by Andrew Ip Breakdown of academic impact, for papers by Penny Taylor Breakdown of academic impact, for papers by Ankie M.T. van der Velden Breakdown of academic impact, for papers by Nahila Justo Breakdown of academic impact, for papers by Robert Hettle Breakdown of academic impact, for papers by Richard Welch Breakdown of academic impact, for papers by Mathieu Puyade Breakdown of academic impact, for papers by Nikita Mehra Breakdown of academic impact, for papers by Seied Asadollah Mousavi
Rankless by CCL
2026